The goal of the artificial pancreas developed by the Inreda Diabetic company in the Netherlands is to unburden people with diabetes. In the treatment of type 1 diabetes, it is crucial to avoid high and low blood glucose levels, keeping the levels ‘within range’. Out-of-range glucose can lead to acute and chronic complications. Currently, people with diabetes are preoccupied with keeping their glucose levels within range. The artificial pancreas assesses and regulates those levels automatically
